Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China
· Delayed Price · Currency is CNY 65.30
+5.18 (8.62%)
Apr 29, 2026, 3:00 PM CST
SHA:603538 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,564 | 1,503 | 1,368 | 1,209 | 1,440 | 1,245 | Upgrade
|
| Other Revenue | - | - | 4.66 | 7.79 | 17.37 | 13.47 | Upgrade
|
| Revenue | 1,564 | 1,503 | 1,373 | 1,216 | 1,457 | 1,258 | Upgrade
|
| Revenue Growth (YoY) | 12.82% | 9.49% | 12.85% | -16.51% | 15.80% | 5.43% | Upgrade
|
| Cost of Revenue | 1,033 | 976.42 | 951.57 | 873.79 | 890.82 | 792.22 | Upgrade
|
| Gross Profit | 531.42 | 526.71 | 421.28 | 342.71 | 566.16 | 465.93 | Upgrade
|
| Selling, General & Admin | 220.37 | 221.37 | 218.15 | 213.97 | 248.85 | 193.53 | Upgrade
|
| Research & Development | 103.92 | 109.35 | 99.65 | 95.3 | 98.16 | 88.31 | Upgrade
|
| Other Operating Expenses | -6.39 | -4.72 | 8.88 | 0.95 | 14.46 | 11.49 | Upgrade
|
| Operating Expenses | 317.91 | 326 | 327.44 | 316.34 | 360.77 | 295.99 | Upgrade
|
| Operating Income | 213.51 | 200.71 | 93.84 | 26.36 | 205.4 | 169.94 | Upgrade
|
| Interest Expense | - | - | -48.27 | -29.06 | -27.45 | -27.08 | Upgrade
|
| Interest & Investment Income | 12.08 | 7.32 | 7.97 | 24.17 | 195.29 | 29.78 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 12.48 | -3.45 | 15.52 | 3.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -57.21 | -46.76 | -4.49 | -2.92 | -1.78 | 1.13 | Upgrade
|
| EBT Excluding Unusual Items | 168.38 | 161.26 | 61.53 | 15.1 | 386.99 | 176.97 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.1 | 4.04 | 4.84 | -18.33 | -6.24 | -5.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.14 | -1.08 | -9.34 | -20.31 | -6.17 | Upgrade
|
| Asset Writedown | -29.22 | -35.38 | - | - | - | -1.43 | Upgrade
|
| Other Unusual Items | - | - | 21.68 | 20.53 | 23.73 | 16.16 | Upgrade
|
| Pretax Income | 138.03 | 129.78 | 86.96 | 7.96 | 384.16 | 180.29 | Upgrade
|
| Income Tax Expense | 22.63 | 23.66 | 10.91 | -8.22 | 16.44 | 22.22 | Upgrade
|
| Earnings From Continuing Operations | 115.4 | 106.12 | 76.05 | 16.18 | 367.73 | 158.07 | Upgrade
|
| Minority Interest in Earnings | -3.23 | -3.89 | -9.24 | -4.6 | -28.87 | -15.54 | Upgrade
|
| Net Income | 112.17 | 102.23 | 66.81 | 11.59 | 338.86 | 142.53 | Upgrade
|
| Net Income to Common | 112.17 | 102.23 | 66.81 | 11.59 | 338.86 | 142.53 | Upgrade
|
| Net Income Growth | 51.61% | 53.02% | 476.63% | -96.58% | 137.75% | -8.62% | Upgrade
|
| Shares Outstanding (Basic) | 216 | 213 | 216 | 232 | 210 | 210 | Upgrade
|
| Shares Outstanding (Diluted) | 224 | 218 | 216 | 232 | 227 | 213 | Upgrade
|
| Shares Change (YoY) | 2.74% | 0.93% | -6.99% | 1.89% | 6.91% | 3.50% | Upgrade
|
| EPS (Basic) | 0.52 | 0.48 | 0.31 | 0.05 | 1.61 | 0.68 | Upgrade
|
| EPS (Diluted) | 0.50 | 0.47 | 0.31 | 0.05 | 1.49 | 0.67 | Upgrade
|
| EPS Growth | 47.57% | 51.61% | 520.00% | -96.64% | 122.39% | -11.70% | Upgrade
|
| Free Cash Flow | 27.96 | 45.48 | -81.87 | -210.41 | -294.67 | -309.26 | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.21 | -0.38 | -0.91 | -1.30 | -1.45 | Upgrade
|
| Dividend Per Share | - | - | 0.050 | 0.020 | 0.165 | 0.142 | Upgrade
|
| Dividend Growth | - | - | 150.00% | -87.88% | 16.11% | - | Upgrade
|
| Gross Margin | 33.97% | 35.04% | 30.69% | 28.17% | 38.86% | 37.03% | Upgrade
|
| Operating Margin | 13.65% | 13.35% | 6.83% | 2.17% | 14.10% | 13.51% | Upgrade
|
| Profit Margin | 7.17% | 6.80% | 4.87% | 0.95% | 23.26% | 11.33% | Upgrade
|
| Free Cash Flow Margin | 1.79% | 3.03% | -5.96% | -17.30% | -20.22% | -24.58% | Upgrade
|
| EBITDA | 347.08 | 333.47 | 223.39 | 139.98 | 303.72 | 268.88 | Upgrade
|
| EBITDA Margin | 22.19% | 22.18% | 16.27% | 11.51% | 20.85% | 21.37% | Upgrade
|
| D&A For EBITDA | 133.57 | 132.76 | 129.55 | 113.62 | 98.32 | 98.94 | Upgrade
|
| EBIT | 213.51 | 200.71 | 93.84 | 26.36 | 205.4 | 169.94 | Upgrade
|
| EBIT Margin | 13.65% | 13.35% | 6.83% | 2.17% | 14.10% | 13.51% | Upgrade
|
| Effective Tax Rate | 16.40% | 18.23% | 12.55% | - | 4.28% | 12.33% | Upgrade
|
| Revenue as Reported | - | - | 1,373 | 1,216 | 1,457 | 1,258 | Upgrade
|
| Advertising Expenses | - | - | 25.77 | 19 | 21.52 | 9.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.